Literature DB >> 17488531

Botulinum toxin injection: a review of injection principles and protocols.

David E Rapp1, Alvaro Lucioni, Gregory T Bales.   

Abstract

Despite the favorable outcomes seen using botulinum toxin (BTX) for voiding dysfunction using BTX, a standardized technique and protocol for toxin injection is not defined. We reviewed the current literature on intravesical BTX injection for DO (detrusor overactivity). Specific attention was placed on defining optimal injection protocol, including dose, volume, and injection sites. In addition, we sought to describe a standard technique to BTX injection.

Mesh:

Substances:

Year:  2007        PMID: 17488531     DOI: 10.1590/s1677-55382007000200002

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  8 in total

Review 1.  New insights into the pharmacology of the bladder.

Authors:  Ann T Hanna-Mitchell; Lori A Birder
Journal:  Curr Opin Urol       Date:  2008-07       Impact factor: 2.309

2.  A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging.

Authors:  Ulrich Mehnert; Sönke Boy; Marius Schmid; André Reitz; Alexander von Hessling; Juerg Hodler; Brigitte Schurch
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

Review 3.  Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.

Authors:  Todd A Linsenmeyer
Journal:  J Spinal Cord Med       Date:  2013-09       Impact factor: 1.985

Review 4.  Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice.

Authors:  Stephanie Knuepfer; Klaus-Peter Juenemann
Journal:  Ther Adv Urol       Date:  2014-02

5.  Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment.

Authors:  S H Alloussi; Ch Lang; R Eichel; A Al-Kaabneh; J Seibold; C Schwentner; S Alloussi
Journal:  World J Urol       Date:  2011-08-13       Impact factor: 4.226

6.  Onabotulinum toxin a (botox®) in the treatment of neurogenic bladder overactivity.

Authors:  Malene Rohrsted; Cecilie Bagi Nordsten; Per Bagi
Journal:  Nephrourol Mon       Date:  2012-03-01

7.  Generalised muscle weakness after bladder wall injection of Abobotulinum Toxin A: experience of a woman with tetraplegia who required increased caregiver support: importance of doctor-patient communication: duty of candour for spinal cord physician and responsibilities of a patient.

Authors:  Subramanian Vaidyanathan; Tracey Foster; Bakul M Soni
Journal:  Spinal Cord Ser Cases       Date:  2018-11-13

8.  The Effects of Intradetrusor BoNT-A Injections on Vesicoureteral Reflux in Children With Myelodysplasia.

Authors:  Tuncay Toprak; Yavuz Onur Danacioglu; Ayhan Verit
Journal:  Int Neurourol J       Date:  2019-12-31       Impact factor: 2.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.